APA (7th ed.) Citation

IP, S., EP, A., M, A., MVG, L., VS, P., AB, S., . . . BB, A. (2021). Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial. Frontiers in immunology, 11, 602589. https://doi.org/10.3389/fimmu.2020.602589

Chicago Style (17th ed.) Citation

IP, Safe, et al. "Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial." Frontiers in Immunology 11 (2021): 602589. https://doi.org/10.3389/fimmu.2020.602589.

MLA (9th ed.) Citation

IP, Safe, et al. "Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial." Frontiers in Immunology, vol. 11, 2021, p. 602589, https://doi.org/10.3389/fimmu.2020.602589.